Enforcement radar
Real enforcement — not just rule changes
FDA & FTC enforcement hitting GLP-1 and compounded products — recalls, warning letters, and FTC actions, each labeled by type. If the pharmacy or outsourcing facility your med spa sources from lands here, that’s a patient-safety and liability problem today — not a rule that might change. Monitoring, not legal advice.
Free weekly Brief
Get the changes that matter in plain English, every week — and be alerted when the rules move. No charge.
Members get the full “what to do” on every alert — in real time, for your states. Become a member →
- CRITICALWARNING LETTERFDA: OAIJul 8, 2026
FDA Warning Letter: Spa De Soleil, Inc. (Drugs)
FDA warns Spa De Soleil over drug compounding practices.
What to do — members only.Become a member →FDA Warning Letterprimary source ↗ - CAUTIONWARNING LETTERJun 23, 2026
FDA Warning Letter: ketaminelab.org (Drugs)
FDA Warning Letter issued to ketaminelab.org for drugs.
What to do — members only.Become a member →FDA Warning Letterprimary source ↗ - CAUTIONFTC ACTIONJun 12, 2026
FTC Files Contempt Motion Against Amare Global and Three Individuals Over Unsubstantiated Health Claims
FTC targets deceptive health claims affecting aesthetic practices.
What to do — members only.Become a member →FTC Enforcementprimary source ↗ - CRITICALFDA ACTIONMay 27, 2026
FDA recall (Class II): Liraglutide Injection, 18 mg/3 mL (6 mg/mL), Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, Fl 34108, …
FDA recalls contaminated Liraglutide Injection; check your inventory!
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFDA ACTIONApr 22, 2026
FDA recall (Class II): Semaglutide-Glycine-Cyanocobalamin Injectable, 2.5 mg, 5 mg, 1 MG/ML, 0.5 mL vials, Rx only, Northwest Compounders, Bea…
FDA recalls semaglutide compound over sterility issues.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFDA ACTIONMar 11, 2026
FDA recall (Class II): Tirzepatide Inj, 10mg, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, Ks 66061, Ndc …
FDA recalls Tirzepatide injection over sterility issues.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - CAUTIONFDA ACTIONMar 11, 2026
FDA recall (Class II): Tirzepatide Inj, 15mg x 4, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, Ks 66061, …
FDA recalls Tirzepatide Inj over sterility concerns; check your stock!
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - CAUTIONFDA ACTIONMar 11, 2026
FDA recall (Class II): Semaglutide, For Rx compounding use only, packaged in a) 1g, Ndc 84385-106-01; b) 5g, Ndc 84385-106-02; c) 10g, Ndc 843…
FDA recalls specific compounded GLP-1 products due to quality issues.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFDA ACTIONMar 11, 2026
FDA recall (Class II): Semaglutide Inj, 2mg x 10, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, Ks 66061, …
FDA recalls compounded GLP-1 product over sterility concerns.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFDA ACTIONMar 11, 2026
FDA recall (Class II): Semaglutide, For Rx compounding use only, packaged in a) 1g, Ndc 84385-106-01; b) 5g, Ndc 84385-106-02; c) 10g, Ndc 843…
Important recall on compounded Semaglutide products affecting med spas.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - CRITICALFDA ACTIONMar 11, 2026
FDA recall (Class II): Semaglutide Inj., 2 mg x 5, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, Ks 66061,…
FDA recalls Semaglutide for sterility issues—act now!
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORDEVICE RECALLJan 28, 2026
FDA device recall (Class II): Brand Name: Leaseir Product Name: Leaseir Mhr Xcell Model/Catalog Number: Mhr 110-b Software Version: 1.5.0.0 Product D…
Leaseir MHR Xcell laser recalled for safety issues.
What to do — members only.Become a member →FDA Device Recallprimary source ↗ - MONITORFDA ACTIONJan 7, 2026
FDA recall (Class II): Wegovy (Semaglutide) Injection, 1 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880 B…
FDA recalls Wegovy due to safety concerns; med spas must act.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - CRITICALFDA ACTIONJan 7, 2026
FDA recall (Class II): Wegovy (Semaglutide) Injection, 0.5 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880…
FDA recalls Wegovy; med spas must check supplies!
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFDA ACTIONNov 5, 2025
FDA recall (Class II): Semaglutide Injection, 10 mg/4 mL (2.5 mg/mL), 4mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Je…
FDA recalls Semaglutide injection over sterility issues; take action!
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFDA ACTIONNov 5, 2025
FDA recall (Class II): Semaglutide Injection, 5 mg/2 mL (2.5 mg/mL), 2mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jef…
FDA recalls GLP-1 product; take immediate action.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - CAUTIONFDA ACTIONNov 5, 2025
FDA recall (Class II): Semaglutide Injection, 2.5mg/1mL (2.5 mg/mL), 1mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jef…
Urgent: FDA recalls compounded semaglutide injection.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFDA ACTIONNov 5, 2025
FDA recall (Class II): Semaglutide Injection, 8mg/3.2mL (2.5 mg/mL), 3.2mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 J…
FDA recalls Semaglutide injection due to sterility issues.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFDA ACTIONNov 5, 2025
FDA recall (Class II): Semaglutide Injection, 12.5/5mL (2.5 mg/mL), 5mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeff…
FDA recalls GLP-1 injection over sterility concerns.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFDA ACTIONNov 5, 2025
FDA recall (Class II): Semaglutide Injection, 6mg/2.4mL (2.5 mg/mL), 2.4mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 J…
FDA recalls Semaglutide injection due to sterility concerns.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFDA ACTIONNov 5, 2025
FDA recall (Class II): Tirzepatide Injection, 27 mg/3 mL (9 mg/mL), 3mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeff…
Urgent FDA recall of Tirzepatide Injection impacts med spas.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFDA ACTIONOct 15, 2025
FDA recall (Class II): Tirzepatide, 60mg/10 mL for Injection, 10mL vial lyophilized, all presentations, GenoGenix, LLC, 2840 Nw 2nd Ave Ste 20…
Important FDA recall on GLP-1 compounded product—act now!
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFDA ACTIONOct 15, 2025
FDA recall (Class II): Semaglutide with B12 for Injection, all strengths and presentations, GenoGenix, LLC, 2840 Nw 2nd Ave Ste 204 Boca Raton…
FDA recalls GLP-1 product over sterility issues.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFDA ACTIONOct 15, 2025
FDA recall (Class II): Semaglutide for Injection, a) 20 mg b) 20 mg/mL, 10 mL Multi-Dose Vials, GenoGenix, LLC, 2840 Nw 2nd Ave Ste 204 Boca R…
FDA recalls semaglutide over sterility issues; check your stock!
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFDA ACTIONSep 10, 2025
FDA recall (Class II): Semaglutide, 2.5 mg/mL injection, 0.8 mL, Boothwyn Pharmacy
Med spas must act on the GLP-1 product recall now!
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - CRITICALFDA ACTIONSep 10, 2025
FDA recall (Class II): Semaglutide, 2.5 mg/mL injection, 2 mL., Boothwyn Pharmacy
FDA recalls compounded GLP-1 product for being subpotent.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFDA ACTIONSep 10, 2025
FDA recall (Class II): Semaglutide, 2.5 mg/mL injection, 4 mL, Boothwyn Pharmacy
Urgent: GLP-1 injection recall for med spas sourcing compounded products.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFDA ACTIONAug 13, 2025
FDA recall (Class II): Tirzepatide + Niacinamide 8.8 mg + 1.0mg/0.5 ml Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2…
Important recall of GLP-1 compounded product—act now!
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFDA ACTIONAug 13, 2025
FDA recall (Class II): Semaglutide + Cyanocobalamin 0.22 mg + 0.25mg/0.5 ml Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Steri…
Alert: GLP-1 product recall due to processing issues.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFDA ACTIONAug 13, 2025
FDA recall (Class II): Semaglutide +Cyanocobalamin 1.5 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile…
FDA recalls compounded GLP-1 product; take immediate action!
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFDA ACTIONAug 13, 2025
FDA recall (Class II): Semaglutide + Cyanocobalamin injection solution, 2.21 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) s…
Stay informed: GLP-1 injectable recall may affect your practice.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFDA ACTIONAug 13, 2025
FDA recall (Class II): Semaglutide + Cyanocobalamin 0.88 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Steri…
Ongoing recall of compounded GLP-1 product: take action now.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFDA ACTIONAug 13, 2025
FDA recall (Class II): Tirzepatide + Niacinamide 4.4 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2…
FDA recalls a GLP-1 product; check your supply immediately.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFDA ACTIONAug 13, 2025
FDA recall (Class II): Tirzepatide + Niacinamide 11.24 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile,…
FDA recalls compounded GLP-1 product over safety issues.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFDA ACTIONAug 13, 2025
FDA recall (Class II): Tirzepatide + Niacinamide 6.6 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2…
Important FDA recall for compounded GLP-1 product impacts med spas.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - CRITICALFDA ACTIONAug 13, 2025
FDA recall (Class II): Semaglutide + Cyanocobalamin 2.67 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Steri…
FDA recalls compounded GLP-1 product; check your stock now!
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFDA ACTIONAug 13, 2025
FDA recall (Class II): Tirzepatide + Niacinamide 13.2 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, …
FDA recalls compounded GLP-1 product due to processing controls issue.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFDA ACTIONAug 13, 2025
FDA recall (Class II): Semaglutide + Cyanocobalamin 0.44 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Steri…
Important recall for compounded GLP-1 products impacts med spas.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFDA ACTIONAug 13, 2025
FDA recall (Class II): Tirzepatide + Niacinamide 2.2 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2…
FDA recalls compounded GLP-1 product due to safety concerns.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - CRITICALFDA ACTIONAug 13, 2025
FDA recall (Class II): Tirzepatide + Niacinamide 16.6 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, …
Important recall for GLP-1 products; take immediate action.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFDA ACTIONJul 2, 2025
FDA recall (Class II): Semaglutide/Cyanocobalamin Injectable, 5mg/1mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Su…
FDA recalls compounded GLP-1 product for sterility issues.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - CRITICALFDA ACTIONJul 2, 2025
FDA recall (Class II): Tirzepatide Injections, 30mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewo…
FDA recalls Tirzepatide injections; action needed now.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFDA ACTIONJul 2, 2025
FDA recall (Class II): Semaglutide, 5 mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, Co 80112
FDA recalls compounded GLP-1 product over sterility issues.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFDA ACTIONJul 2, 2025
FDA recall (Class II): Tirzepatide/Cyanocobalamin Injectable, 15mg/1mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, S…
Recall alert: Check your GLP-1 injectable supplies now!
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFDA ACTIONJul 2, 2025
FDA recall (Class II): Tirzepatide/Cyanocobalamin Injectable, 30mg/1mg/mL (15mg/0.5mg/0.5mL), pre-filled syringe, Thrive Health Solutions, 88 …
FDA recalls GLP-1 product due to sterility concerns.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - CRITICALFDA ACTIONJul 2, 2025
FDA recall (Class II): Semaglutide, 2.5 mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, Co 80…
FDA recalls GLP-1 product over sterility issues.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFDA ACTIONJul 2, 2025
FDA recall (Class II): Tirzepatide Injections, 10mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewo…
FDA recalls Tirzepatide due to sterility concerns - take action now!
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - MONITORFDA ACTIONJul 2, 2025
FDA recall (Class II): Tirzepatide Injections, 20mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewo…
FDA recalls Tirzepatide for sterility issues; take action now.
What to do — members only.Become a member →FDA Enforcementprimary source ↗ - CRITICALFDA ACTIONMay 7, 2025
FDA recall (Class II): Wegovy (Semaglutide) injection, 2.4 mg/0.75 mL, 4 Single-Dose Prefilled Pens per Carton, For Subcutaneous Use Only, Rx …
Urgent recall of Wegovy due to temperature abuse risks.
What to do — members only.Become a member →FDA Enforcementprimary source ↗
Want this watched for your states + the full radar? Claim founding access →